Figure 3 | Cell Death & Disease

Figure 3

From: Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration

Figure 3

Downregulation of cdr2 in brains from post-mortem PD patients. (a) Characteristics of PD patients and age-matched controls, including diagnosis, age, sex, race, and post-mortem delay (PMD; h). (b) Tissue lysates from the SN of post-mortem humans were subjected to immunoblot analysis using anti-cdr2 antibody and anti-HSP70 antibody. After normalization against GAPDH, relative intensity of cdr2 in brains from post-mortem PD patients or age-matched controls. Data are shown as mean±S.D. **P<0.01

Back to article page